[ Back to EurekAlert! ]

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute

Wolfram Goessling, M.D., Ph.D., Dana-Farber Cancer Institute

Caption: Wolfram Goessling, M.D., Ph.D., and colleagues demonstrated that an innovative experimental treatment for boosting the effectiveness of stem-cell transplants with umbilical cord blood has a favorable safety profile in long-term animal studies.

Credit: Sam Ogden

Usage Restrictions: None

Related news release: Enhanced cord blood stem cell transplants safe in long-term studies


[ Back to EurekAlert! ]